Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Gastroenteropancreatic neuroendocrine neoplasia G3 according to 2019 WHO classification: a comprehensive clinicopathological characterization including mismatch repair proteins and PDL1 expression in a large cohort of patients.

Grasselli J, Rizzolo M, Ruiz G, Salanova R, Mariani J, O'Connor J, Luca R, Cabanne A, Mendez G, Roca E.

Ann Oncol. 2019 Jul;30 Suppl 4:iv25. doi: 10.1093/annonc/mdz155.094. Epub 2019 Dec 4. No abstract available.

PMID:
32085097
2.

Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab.

Pantano F, Russano M, Berruti A, Mansueto G, Migliorino MR, Adamo V, Aprile G, Gelibter A, Ficorella C, Falcone A, Russo A, Aieta M, Maio M, Martelli O, Barni S, Napolitano A, Roca E, Quadrini S, Iacono D, Russo A, Calvetti L, Occhipinti MA, Cortellini A, Vasile E, Passiglia F, Imperatori M, Calabrò L, Di Giacomo AM, Petrelli F, Pasquini G, Franchina T, Venditti O, Intagliata S, Galvano A, Fioroni I, Vincenzi B, Tonini G, Santini D.

Expert Opin Biol Ther. 2020 Mar;20(3):319-326. doi: 10.1080/14712598.2020.1724953. Epub 2020 Feb 6.

PMID:
32011207
3.

Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study.

Russo A, Russano M, Franchina T, Migliorino MR, Aprile G, Mansueto G, Berruti A, Falcone A, Aieta M, Gelibter A, Russo A, Barni S, Maio M, Martelli O, Pantano F, Iacono D, Calvetti L, Quadrini S, Roca E, Vasile E, Imperatori M, Occhipinti M, Galvano A, Petrelli F, Calabrò L, Pasquini G, Intagliata S, Ricciardi GRR, Tonini G, Santini D, Adamo V.

Adv Ther. 2020 Jan 30. doi: 10.1007/s12325-020-01229-w. [Epub ahead of print]

PMID:
32002809
4.

Tumor Infiltrating Neutrophils Are Enriched in Basal-Type Urothelial Bladder Cancer.

Mandelli GE, Missale F, Bresciani D, Gatta LB, Scapini P, Caveggion E, Roca E, Bugatti M, Monti M, Cristinelli L, Belotti S, Simeone C, Calza S, Melocchi L, Vermi W.

Cells. 2020 Jan 25;9(2). pii: E291. doi: 10.3390/cells9020291.

5.

Stimulation-related intraoperative seizures during awake surgery: a review of available evidences.

Roca E, Pallud J, Guerrini F, Panciani PP, Fontanella M, Spena G.

Neurosurg Rev. 2020 Feb;43(1):87-93. doi: 10.1007/s10143-019-01214-0. Epub 2019 Dec 3. Review.

PMID:
31797239
6.

Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non-small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy.

Dal Maso A, Lorenzi M, Roca E, Pilotto S, Macerelli M, Polo V, Cecere FL, Del Conte A, Nardo G, Buoro V, Scattolin D, Monteverdi S, Urso L, Zulato E, Frega S, Bonanno L, Indraccolo S, Calabrese F, Conte P, Pasello G.

Clin Lung Cancer. 2020 Jan;21(1):1-14.e3. doi: 10.1016/j.cllc.2019.07.009. Epub 2019 Aug 5.

PMID:
31601525
7.

Risk factors for intraoperative stimulation-related seizures during awake surgery: an analysis of 109 consecutive patients.

Spena G, Roca E, Guerrini F, Panciani PP, Stanzani L, Salmaggi A, Luzzi S, Fontanella M.

J Neurooncol. 2019 Nov;145(2):295-300. doi: 10.1007/s11060-019-03295-9. Epub 2019 Sep 24.

PMID:
31552589
8.

Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: A multicentre retrospective study.

Ravanelli M, Agazzi GM, Milanese G, Roca E, Silva M, Tiseo M, Rondi P, Baggi A, Ganeshan B, Muri M, Panni S, Botti C, Sverzellati N, Maroldi R, Berruti A, Farina D.

Eur J Radiol. 2019 Sep;118:251-256. doi: 10.1016/j.ejrad.2019.07.019. Epub 2019 Jul 17.

PMID:
31439251
9.

Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial.

Santo A, Pilotto S, Galetta D, Grossi F, Fasola G, Romano G, Bonanno L, Bearz A, Papi M, Roca E, Catino A, Follador A, Rijavec E, Genova C, Petrillo P, Favaretto A, Giannone L, Milella M, Tortora G, Giannarelli D, Bria E; Italian association FONICAP (Operative National Interdisciplinary Force against Lung Cancer).

Lung Cancer. 2019 Aug;134:121-126. doi: 10.1016/j.lungcan.2019.06.011. Epub 2019 Jun 11.

PMID:
31319970
10.

Are convexity meningiomas all the same? A clinico-radiological analysis of surgically treated eloquent areas convexity meningiomas.

Spena G, Guerrini F, Decet P, D'agata F, Roca E, Belotti F, Nucci CG, Fontanella MM.

J Neurosurg Sci. 2019 Jul 11. doi: 10.23736/S0390-5616.19.04713-1. [Epub ahead of print]

PMID:
31298505
11.

Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy.

Ravanelli M, Agazzi GM, Tononcelli E, Roca E, Cabassa P, Baiocchi G, Berruti A, Maroldi R, Farina D.

Radiol Med. 2019 Sep;124(9):877-886. doi: 10.1007/s11547-019-01046-4. Epub 2019 Jun 6.

PMID:
31172448
12.

Surgery of the lateral skull base: a 50-year endeavour.

Zanoletti E, Mazzoni A, Martini A, Abbritti RV, Albertini R, Alexandre E, Baro V, Bartolini S, Bernardeschi D, Bivona R, Bonali M, Borghesi I, Borsetto D, Bovo R, Breun M, Calbucci F, Carlson ML, Caruso A, Cayé-Thomasen P, Cazzador D, Champagne PO, Colangeli R, Conte G, D'Avella D, Danesi G, Deantonio L, Denaro L, Di Berardino F, Draghi R, Ebner FH, Favaretto N, Ferri G, Fioravanti A, Froelich S, Giannuzzi A, Girasoli L, Grossardt BR, Guidi M, Hagen R, Hanakita S, Hardy DG, Iglesias VC, Jefferies S, Jia H, Kalamarides M, Kanaan IN, Krengli M, Landi A, Lauda L, Lepera D, Lieber S, Lloyd SLK, Lovato A, Maccarrone F, Macfarlane R, Magnan J, Magnoni L, Marchioni D, Marinelli JP, Marioni G, Mastronardi V, Matthies C, Moffat DA, Munari S, Nardone M, Pareschi R, Pavone C, Piccirillo E, Piras G, Presutti L, Restivo G, Reznitsky M, Roca E, Russo A, Sanna M, Sartori L, Scheich M, Shehata-Dieler W, Soloperto D, Sorrentino F, Sterkers O, Taibah A, Tatagiba M, Tealdo G, Vlad D, Wu H, Zanetti D.

Acta Otorhinolaryngol Ital. 2019 Jun;39(SUPPL. 1):S1-S146. doi: 10.14639/0392-100X-suppl.1-39-2019.

13.

Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents.

Tucci M, Roca E, Ferrari L, Pia A, Dalla Volta A, Bedussi F, Buttigliero C, Vittorio Scagliotti G, Sigala S, Berruti A.

Endocrine. 2019 Jun;64(3):724-726. doi: 10.1007/s12020-019-01947-4. Epub 2019 May 7. No abstract available.

PMID:
31065911
14.

When a benign disease turns into disaster: a unique case of a surgically treated hemorrhagic sylvian fissure meningioma.

Guerrini F, Roca E, Verlotta M, Grimod G, Spena G.

J Neurosurg Sci. 2019 Apr 2. doi: 10.23736/S0390-5616.19.04689-7. [Epub ahead of print] No abstract available.

PMID:
30942054
15.

Effects of a polysaccharide-based multi-ingredient supplement on salivary immunity in non-elite marathon runners.

Roca E, Cantó E, Nescolarde L, Perea L, Bayes-Genis A, Sibila O, Vidal S.

J Int Soc Sports Nutr. 2019 Mar 25;16(1):14. doi: 10.1186/s12970-019-0281-z.

16.

Fibre-type-specific and Mitochondrial Biomarkers of Muscle Damage after Mountain Races.

Carmona G, Roca E, Guerrero M, Cussó R, Bàrcena C, Mateu M, Cadefau JA.

Int J Sports Med. 2019 Apr;40(4):253-262. doi: 10.1055/a-0808-4692. Epub 2019 Mar 5.

PMID:
30836391
17.

Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines.

Fragni M, Galli D, Nardini M, Rossini E, Vezzoli S, Zametta M, Longhena F, Bellucci A, Roca E, Memo M, Berruti A, Sigala S.

Naunyn Schmiedebergs Arch Pharmacol. 2019 Jun;392(6):729-742. doi: 10.1007/s00210-019-01622-5. Epub 2019 Feb 15.

PMID:
30770950
18.

Three-Dimensional High-Definition Ventriculoscope: Single-Center Case Series.

Doglietto F, Belotti F, Nucci CG, Roca E, Mattogno PP, Zappa F, Migliorati K, Panciani PP, Spena G, Cereda C, Cornali C, Fontanella MM.

World Neurosurg. 2019 May;125:e978-e983. doi: 10.1016/j.wneu.2019.01.219. Epub 2019 Feb 11.

PMID:
30763750
19.

Lynch-like syndrome is as frequent as Lynch syndrome in early-onset nonfamilial nonpolyposis colorectal cancer.

Antelo M, Golubicki M, Roca E, Mendez G, Carballido M, Iseas S, Cuatrecasas M, Moreira L, Sanchez A, Carballal S, Castells A, Boland CR, Goel A, Balaguer F.

Int J Cancer. 2019 Aug 1;145(3):705-713. doi: 10.1002/ijc.32160. Epub 2019 Feb 23.

PMID:
30693488
20.

Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case.

Roca E, Pozzari M, Vermi W, Tovazzi V, Baggi A, Amoroso V, Nonnis D, Intagliata S, Berruti A.

Lung Cancer. 2019 Jan;127:12-18. doi: 10.1016/j.lungcan.2018.11.016. Epub 2018 Nov 13. Review.

PMID:
30642539
21.

Endonasal and Transoral Approaches to the Craniovertebral Junction: A Quantitative Anatomical Study.

Doglietto F, Belotti F, Qiu J, Roca E, Radovanovic I, Agur A, Kucharczyk W, Schreiber A, Villaret AB, Nicolai P, Gentili F, Fontanella MM.

Acta Neurochir Suppl. 2019;125:37-44. doi: 10.1007/978-3-319-62515-7_6.

PMID:
30610300
22.

CT texture analysis as predictive factor in metastatic lung adenocarcinoma treated with tyrosine kinase inhibitors (TKIs).

Ravanelli M, Agazzi GM, Ganeshan B, Roca E, Tononcelli E, Bettoni V, Caprioli A, Borghesi A, Berruti A, Maroldi R, Farina D.

Eur J Radiol. 2018 Dec;109:130-135. doi: 10.1016/j.ejrad.2018.10.016. Epub 2018 Oct 24.

PMID:
30527295
23.

Salivary immunity and lower respiratory tract infections in non-elite marathon runners.

Cantó E, Roca E, Perea L, Rodrigo-Troyano A, Suarez-Cuartin G, Giner J, Feliu A, Soria JM, Nescolarde L, Vidal S, Sibila O.

PLoS One. 2018 Nov 21;13(11):e0206059. doi: 10.1371/journal.pone.0206059. eCollection 2018.

24.

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations.

Passiglia F, Cappuzzo F, Alabiso O, Bettini AC, Bidoli P, Chiari R, Defferrari C, Delmonte A, Finocchiaro G, Francini G, Gelsomino F, Giannarelli D, Giordano M, Illiano A, Livi L, Martelli O, Natoli C, Puppo G, Ricevuto E, Roca E, Turci D, Galetta D.

Br J Cancer. 2019 Jan;120(1):57-62. doi: 10.1038/s41416-018-0234-3. Epub 2018 Oct 31.

25.

Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice.

Intagliata S, Roca E, Cosentini D, Berruti A.

Ann Transl Med. 2018 Sep;6(18):369. doi: 10.21037/atm.2018.07.24. No abstract available.

26.

Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial.

Romera A, Peredpaya S, Shparyk Y, Bondarenko I, Mendonça Bariani G, Abdalla KC, Roca E, Franke F, Melo Cruz F, Ramesh A, Ostwal V, Shah P, Rahuman SA, Paravisini A, Huerga C, Del Campo García A, Millán S.

Lancet Gastroenterol Hepatol. 2018 Dec;3(12):845-855. doi: 10.1016/S2468-1253(18)30269-3. Epub 2018 Sep 24. Erratum in: Lancet Gastroenterol Hepatol. 2018 Sep 28;:.

PMID:
30262136
27.

Abdominal Fat Graft for Sellar Reconstruction: Retrospective Outcomes Review and Technical Note.

Roca E, Penn DL, Safain MG, Burke WT, Castlen JP, Laws ER.

Oper Neurosurg (Hagerstown). 2019 Jun 1;16(6):667-674. doi: 10.1093/ons/opy219.

PMID:
30124966
28.

Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options.

Puglisi S, Perotti P, Cosentini D, Roca E, Basile V, Berruti A, Terzolo M.

Expert Rev Anticancer Ther. 2018 Nov;18(11):1125-1133. doi: 10.1080/14737140.2018.1510325. Epub 2018 Aug 21. Review.

PMID:
30117750
29.

Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study.

Pedersini R, Vassalli L, Claps M, Tulla A, Rodella F, Grisanti S, Amoroso V, Roca E, Simoncini EL, Berruti A.

Oncology. 2018;94 Suppl 1:10-15. doi: 10.1159/000489063. Epub 2018 Jul 23.

30.

Osimertinib in EGFR Mutation–Positive Advanced NSCLC.

Roca E, Amoroso V, Berruti A.

N Engl J Med. 2018 Mar 29;378(13):1261-2. doi: 10.1056/NEJMc1801669. No abstract available.

PMID:
29595923
31.

Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma.

Grisanti S, Cosentini D, Tovazzi V, Bianchi S, Lazzari B, Consoli F, Roca E, Berruti A, Ferrari VD.

Support Care Cancer. 2018 Aug;26(8):2929-2935. doi: 10.1007/s00520-018-4129-x. Epub 2018 Mar 15.

PMID:
29546526
32.

IFN-α in advanced well-differentiated neuroendocrine tumors: the neglected drug?

Amoroso V, Pavel M, Claps M, Roca E, Ravanelli M, Maroldi R, Oberg K, Berruti A.

Future Oncol. 2018 Apr;14(10):897-899. doi: 10.2217/fon-2017-0667. Epub 2018 Mar 12. No abstract available.

PMID:
29528242
33.

Plurihormonal ACTH-GH Pituitary Adenoma: Case Report and Systematic Literature Review.

Roca E, Mattogno PP, Porcelli T, Poliani L, Belotti F, Schreiber A, Maffezzoni F, Fontanella MM, Doglietto F.

World Neurosurg. 2018 Jun;114:e158-e164. doi: 10.1016/j.wneu.2018.02.120. Epub 2018 Mar 6. Review.

PMID:
29501516
34.

Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis.

Claps M, Petrelli F, Caffo O, Amoroso V, Roca E, Mosca A, Maines F, Barni S, Berruti A.

Clin Genitourin Cancer. 2018 Jun;16(3):165-175.e2. doi: 10.1016/j.clgc.2018.01.005. Epub 2018 Feb 2.

PMID:
29454638
35.

Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience.

Borghetti P, Bonù ML, Roca E, Pedretti S, Salah E, Baiguini A, Greco D, Triggiani L, Maddalo M, Levra NG, Alongi F, Magrini SM, Buglione M.

In Vivo. 2018 Jan-Feb;32(1):159-164.

36.

How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension.

Tocci G, Desideri G, Roca E, Calcullo C, Crippa M, De Luca N, Gaudio GV, Lonati LM, Orselli L, Scuteri A, Vulpis V, Acone B, Zaninelli A; THYPERevolution Steering Committee.

High Blood Press Cardiovasc Prev. 2018 Mar;25(1):25-34. doi: 10.1007/s40292-017-0242-z. Epub 2017 Dec 2. Review.

37.

Affected pathways and transcriptional regulators in gene expression response to an ultra-marathon trail: Global and independent activity approaches.

Maqueda M, Roca E, Brotons D, Soria JM, Perera A.

PLoS One. 2017 Oct 13;12(10):e0180322. doi: 10.1371/journal.pone.0180322. eCollection 2017.

38.

Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma.

Claps M, Cerri S, Grisanti S, Lazzari B, Ferrari V, Roca E, Perotti P, Terzolo M, Sigala S, Berruti A.

Endocrine. 2018 Jul;61(1):169-172. doi: 10.1007/s12020-017-1428-9. Epub 2017 Oct 10. No abstract available.

39.

Pulmonary Vascular Function and Aerobic Exercise Capacity at Moderate Altitude.

Faoro V, Deboeck G, Vicenzi M, Gaston AF, Simaga B, Doucende G, Hapkova I, Roca E, Subirats E, Durand F, Naeije R.

Med Sci Sports Exerc. 2017 Oct;49(10):2131-2138. doi: 10.1249/MSS.0000000000001320.

PMID:
28915226
40.

Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis.

Roca E, Gurizzan C, Amoroso V, Vermi W, Ferrari V, Berruti A.

Cancer Treat Rev. 2017 Sep;59:117-122. doi: 10.1016/j.ctrv.2017.07.007. Epub 2017 Jul 31. Review.

PMID:
28806542
41.

Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity.

Bedussi F, Galli D, Fragni M, Valcamonico F, Rossini E, Dalla Volta A, Vezzoli S, Roca E, Ferrari V, Lazzari B, Memo M, Sigala S, Berruti A.

Pharmacology. 2017;100(5-6):261-268. doi: 10.1159/000477547. Epub 2017 Aug 11.

PMID:
28797006
42.

The impact of moderate altitude on exercise metabolism in recreational sportsmen: a nuclear magnetic resonance metabolomic approach.

Messier FM, Le Moyec L, Santi C, Gaston AF, Triba MN, Roca E, Durand F.

Appl Physiol Nutr Metab. 2017 Nov;42(11):1135-1141. doi: 10.1139/apnm-2016-0717. Epub 2017 Jun 30.

PMID:
28666093
43.

MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects.

Mazziotti G, Formenti AM, Frara S, Roca E, Mortini P, Berruti A, Giustina A.

Eur J Endocrinol. 2017 Nov;177(5):R231-R248. doi: 10.1530/EJE-17-0154. Epub 2017 Jun 5. Review.

PMID:
28583942
44.

New Oral Anticoagulants and Pituitary Apoplexy.

Doglietto F, Roca E, La Rocca G, Schreiber A, Bolzoni Villaret A, Nicolai P, Fontanella MM.

World Neurosurg. 2017 Apr;100:700. doi: 10.1016/j.wneu.2016.12.010. No abstract available.

PMID:
28437880
45.

Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer.

Roca E, Berruti A, Sbiera S, Rapa I, Oneda E, Sperone P, Ronchi CL, Ferrari L, Grisanti S, Germano A, Zaggia B, Scagliotti GV, Fassnacht M, Volante M, Terzolo M, Papotti M.

Endocr Relat Cancer. 2017 Jul;24(7):319-327. doi: 10.1530/ERC-17-0095. Epub 2017 Apr 21.

PMID:
28432084
46.

The Dynamics of Cardiovascular Biomarkers in non-Elite Marathon Runners.

Roca E, Nescolarde L, Lupón J, Barallat J, Januzzi JL, Liu P, Cruz Pastor M, Bayes-Genis A.

J Cardiovasc Transl Res. 2017 Apr;10(2):206-208. doi: 10.1007/s12265-017-9744-2. Epub 2017 Apr 5.

PMID:
28382580
47.

Palbociclib inhibits proliferation of human adrenocortical tumor cells.

Fiorentini C, Fragni M, Tiberio GAM, Galli D, Roca E, Salvi V, Bosisio D, Missale C, Terzolo M, Memo M, Berruti A, Sigala S.

Endocrine. 2018 Jan;59(1):213-217. doi: 10.1007/s12020-017-1270-0. Epub 2017 Mar 6. No abstract available.

PMID:
28265858
48.

Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions.

Froudarakis ME, Plojoux J, Kaspi E, Anevlavis S, Laroumagne S, Karpathiou G, Roca E, Adler D, Dutau H, Astoul P.

Clin Respir J. 2018 Mar;12(3):1011-1016. doi: 10.1111/crj.12619. Epub 2017 Mar 15.

PMID:
28245530
49.

Daily activity rhythms and the stress-related response in the wedge sole (Dicologoglossa cuneata Moreau, 1881).

De la Roca E, Sánchez B, López JM, Herves MA, Canalejo A, Herrera M.

Physiol Behav. 2017 May 1;173:272-278. doi: 10.1016/j.physbeh.2017.02.029. Epub 2017 Feb 24.

PMID:
28238779
50.

When Should Everolimus Be Administered in the Natural History of Pancreatic Neuroendocrine Tumors?

Amoroso V, Fazio N, Mosca A, Roca E, Spada F, Foroni C, Agazzi GM, Berruti A.

J Clin Oncol. 2017 May 1;35(13):1487-1488. doi: 10.1200/JCO.2016.71.0103. Epub 2017 Jan 23. No abstract available.

PMID:
28113025

Supplemental Content

Support Center